Background: Both metabolic syndrome (MetSyn) and the
Renin Angiotensin Aldosterone System (RAAS) are predictors of adverse outcomes
in stroke patients. This study aimed at evaluating the association between RAAS and MetSyn among ischaemic stroke subjects in a
tertiary hospital of Ghana from September
2015 to June 2016. Methodology: The study purposively recruited 252 Ghanaians
comprising 132 ischaemic stroke patients and 120 apparently healthy control subjects. The participants were subjected to measurements of plasma renin,
serum aldosterone, lipid profile, anthropometries and blood pressure. Results: MetSyn prevalence among the stroke subjects compared to the
controls were 50.0% vs 8.3% (NCEP/ATP III), 71.2% vs 9.2 (IDF) and 71.2% vs
6.7% (H_MS). Both renin and aldosterone were significantly (p < 0.05) higher in the ischaemic
stroke subjects [(1.8 ± 0.1 vs 1.4 ± 0.1) pg/ml and (2.9 ± 0.2 vs 2.3 ± 0.2) pg/ml respectively]. Adjusting for age, gender,
diabetes status and hypertension, third tertile (T3) aldosterone
(aOR = 2.7, p = 0.008), obesity (aOR
= 11.7, p = 0.004) and high
triglyceride (aOR = 5.3, p < 0.001)
but not renin (aOR = 6.1, p = 0.742)
were independently associated with increasing odds of metabolic syndrome. Moreover, there was a significant (p < 0.050) correlation between plasma
renin and waist circumference (WC) (r = 0.493) and high density lipoprotein (HDL) (r = ﹣0.319). Significant (p < 0.050) correlations also existed
between serum aldosterone and WC (r = 0.588), waist-to-height ratio (WHR) (r =
0.503), body mass index (BMI) (r = 0.691), HDL (r = ﹣0.317), total cholesterol
(r = 0.678) and triglyceride (r = 0.439). Conclusion: Aldosterone and not renin
could play significant role in the pathophysiology of metabolic syndrome in
ischaemic stroke. These findings underpin the observations that aldosterone is
associated with several cardiovascular risk factors and may exacerbate
metabolic defects in people with ischaemic stroke. Adequate aldosterone
blockade could therefore mitigate the development and progression of metabolic
syndrome in ischaemic stroke subjects.
Cite this paper
Yeboah, F. A. , Nkum, B. , Amankwaa, B. , Jr., B. A. E. , Acheampong, E. , Nsiah, P. , Okyere, P. , Owusu, L. , Nsenba, E. B. and Anto, E. O. (2017). Metabolic Syndrome among Ischaemic Stroke Patients in Ghana: The Possible Role of Renin and Aldosterone. Open Access Library Journal, 4, e3952. doi: http://dx.doi.org/10.4236/oalib.1103952.
Boldyreff, B. and Wehling, M. (2003) Non-Genomic Actions of Aldosterone: Mechanisms and Consequences in Kidney Cells. Nephrology Dialysis Transplantation, 18, 1693-1695. https://doi.org/10.1093/ndt/gfg265
Alberti, K.G.M., Zimmet, P. and Shaw, J. (2005) The Metabolic Syndrome—A New Worldwide Definition. The Lancet, 366, 1059-1062. https://doi.org/10.1016/S0140-6736(05)67402-8
Wang, C.-H., Li, F. and Takahashi, N. (2010) The Renin Angiotensin System and the Metabolic Syndrome. The Open Hypertension Journal, 3, 1-13. https://doi.org/10.2174/1876526201003010001
Abdou, M., AbdElGawad, M.S. and Mohamed, S.A. (2013) Increased Aldosterone in Patients with Metabolic Syndrome: An Additional Risk Factor. Journal of Diabetes Research and Clinical Metabolism, 2, 17.
Mathew, B. (2014) Incidence of Metabolic Syndrome in Ischemic Stroke Patients in South Indian Population. International Journal of Pharmaceutical and Phytopharmacological Research, 3, 110-113.
Akpalu, J., Akpalu, A. and Ofei, F. (2011) The Metabolic Syndrome among Patients with Cardiovascular Disease in Accra, Ghana. Ghana Medical Journal, 45, 161-166.
Stiefel, P., Vallejo-Vaz, A., García Morillo, S. and Villar, J. (2011) Role of the Renin-Angiotensin System and Al-dosterone on Cardiometabolic Syndrome. International Journal of Hypertension, 2011, 685238.
Engeli, S. (2006) Role of the Renin-Angiotensin-Aldosterone System in the Metabolic Syndrome. In: Obesity and the Kidney, Volume 151, Karger Publishers, Basel, 122-134.
Ashtari, F., Salari, M., Amminoroaya, A., Deljoo, B.K. and Moeini, M. (2012) Metabolic Syndrome in Ischemic Stroke: A Case-Control Study. Journal of Research in Medical Sciences, 17, 167-170.
Sarzani, R., Salvi, F., Dessì-Fulgheri, P. and Rappelli, A. (2008) Renin-Angiotensin System, Natriuretic Peptides, Obesity, Metabolic Syndrome, and Hypertension: An Integrated View in Humans. Journal of Hypertension, 26, 831-843. https://doi.org/10.1097/HJH.0b013e3282f624a0
Tirosh, A., Garg, R. and Adler, G.K. (2010) Mineralocorticoid Receptor Antagonists and the Metabolic Syndrome. Current Hypertension Reports, 12, 252-257. https://doi.org/10.1007/s11906-010-0126-2
Vogt, B., Bochud, M. and Burnier, M. (2007) The Association of Aldosterone with Obesity-Related Hypertension and the Metabolic Syndrome. In: Seminars in Nephrology, Elsevier, 529-537.
Agyemang, C., Attah-Adjepong, G., Owusu-Dabo, E., Aikins, A.D.G., Addo, J., Edusei, A., Nkum, B. and Ogedegbe, G. (2012) Stroke in Ashanti Region of Ghana. Ghana Medical Journal, 46, 12-17.
Saiedullah, M., Sarkar, A., Kamaluddin, S.M., Begum, S., Hayat, S., Rahman, M.R. and Khan, M.A.H. (2011) Friedewald’s Formula Is Applicable up to Serum Triacylglycerol to Total Cholesterol Ratio of Two in Bangladeshi Population. Anwer Khan Modern Medical College Journal, 2, 21-25.
Shen, J., Tryon, D., Myklak, K., Alsyouf, M., Peplinski, B., Conceicao, C., Ruckle, H., Baldwin, D., Liu, L. and Johnson, L. (2015) Scientific Program of 33rd World Congress of Endourology & SWL Program Book. Journal of Endourology, 29, P1-A457. https://doi.org/10.1089/end.2015.29003.abstracts
Tomaschitz, A., Maerz, W., Pilz, S., Ritz, E., Scharnagl, H., Renner, W., Boehm, B.O., Fahrleitner-Pammer, A., Weihrauch, G. and Dobnig, H. (2010) Aldosterone/Renin Ratio Determines Peripheral and Central Blood Pressure Values over a Broad Range. Journal of the American College of Cardiology, 55, 2171-2180.
Stevens, L.A., Schmid, C.H., Greene, T., Zhang, Y.L., Beck, G.J., Froissart, M., Hamm, L.L., Lewis, J.B., Mauer, M. and Navis, G.J. (2010) Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels above 60 mL/min/1.73 m 2. American Journal of Kidney Diseases, 56, 486-495. https://doi.org/10.1053/j.ajkd.2010.03.026
Alberti, K.G.M.M., Zimmet, P. and Shaw, J. (2006) Metabolic Syndrome—A New World-Wide Definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine, 23, 469-480. https://doi.org/10.1111/j.1464-5491.2006.01858.x
Palomeras Soler, E. and Casado Ruiz, V. (2010) Epidemiology and Risk Factors of Cerebral Ischemia and Ischemic Heart Diseases: Similarities and Differences. Current Cardiology Reviews, 6, 138-149. https://doi.org/10.2174/157340310791658785
Kidambi, S., Kotchen, J.M., Grim, C.E., Raff, H., Mao, J., Singh, R.J. and Kotchen, T.A. (2007) Association of Adrenal Steroids with Hypertension and the Metabolic Syndrome in Blacks. Hypertension, 49, 704-711. https://doi.org/10.1161/01.HYP.0000253258.36141.c7
McKinley, M., Albiston, A., Allen, A., Mathai, M., May, C., McAllen, R., Oldfield, B., Mendelsohn, F. and Chai, S. (2003) The Brain Renin-Angiotensin System: Location and Physiological Roles. The International Journal of Biochemistry & Cell Biology, 35, 901-918.
Allen, A., Oldfield, B., Giles, M., Paxinos, G., McKinley, M. and Mendelsohn, F. (2000) Chapter III Localization of Angiotensin Receptors in the Nervous System. Handbook of Chemical Neuroanatomy, 16, 79-124.
Baltatu, O.C., Campos, L.A. and Bader, M. (2011) Local Renin-Angiotensin System and the Brain—A Continuous Quest for Knowledge. Peptides, 32, 1083-1086.
MacLeod, A.B., Vasdev, S. and Smeda, J.S. (1997) The Role of Blood Pressure and Aldosterone in the Production of Hemorrhagic Stroke in Captopril-Treated Hypertensive Rats. Stroke, 28, 1821-1829. https://doi.org/10.1161/01.STR.28.9.1821
Barceló, A., Piérola, J., Esquinas, C., de la Pena, M., Arqué, M., Alonso-Fernández, A., Baucà, J.M., Robles, J., Barceló, B. and Barbé, F. (2014) Relationship between Aldosterone and the Metabolic Syndrome in Patients with Obstructive Sleep Apnea Hypopnea Syndrome: Effect of Continuous Positive Airway Pressure Treatment. PLoS ONE, 9, e84362.
https://doi.org/10.1371/journal.pone.0084362
Bochud, M., Nussberger, J., Bovet, P., Maillard, M.R., Elston, R.C., Paccaud, F., Shamlaye, C. and Burnier, M. (2006) Plasma Aldosterone Is Independently Associated with the Metabolic Syndrome. Hypertension, 48, 239-245. https://doi.org/10.1161/01.HYP.0000231338.41548.fc
Sun, Y., Zhang, J., Lu, L., Chen, S.S., Quinn, M.T. and Weber, K.T. (2002) Aldosterone-Induced Inflammation in the Rat Heart: Role of Oxidative Stress. The American Journal of Pathology, 161, 1773-1781.
Sato, A., Hayashi, K. and Saruta, T. (2005) Antiproteinuric Effects of Miner-alocorticoid Receptor Blockade in Patients with Chronic Renal Disease. American Journal of Hypertension, 18, 44-49.
Goodfriend, T., Egan, B. and Kelley, D. (1999) Plasma Aldosterone, Plasma Lipoproteins, Obesity and Insulin Resistance in Humans. Prostaglandins, Leukotrienes and Essential Fatty Acids, 60, 401-405.
Oelkers, W., Foidart, J.-M., Dombrovicz, N., Welter, A. and Heithecker, R. (1995) Effects of a New Oral Contraceptive Containing an Antimineralocorticoid Progestogen, Drospirenone, on the Renin-Aldosterone System, Body Weight, Blood Pressure, Glucose Tolerance, and Lipid Metabolism. The Journal of Clinical Endocrinology & Metabolism, 80, 1816-1821.
Egan, B.M., Stepniakowski, K. and Goodfriend, T.L. (1994) Renin and Aldosterone Are Higher and the Hyperinsulinemic Effect of Salt Restriction Greater in Subjects with Risk Factors Clustering. American Journal of Hypertension, 7, 886-893. https://doi.org/10.1093/ajh/7.10.886
Joseph, J.J., Echouffo-Tcheugui, J.B., Kalyani, R.R., Yeh, H.-C., Bertoni, A.G., Effoe, V.S., Casanova, R., Sims, M., Correa, A. and Wu, W.-C. (2016) Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study. The Journal of Clinical Endocrinology & Metabolism, 101, 1770-1778. https://doi.org/10.1210/jc.2016-1002
Abiko, H., Konta, T., Hao, Z., Takasaki, S., Suzuki, K., Ichikawa, K., Ikeda, A., Shibata, Y., Takeishi, Y. and Kawata, S. (2009) Factors Correlated with Plasma Renin Activity in General Japanese Population. Clinical and Experimental Nephrology, 13, 130. https://doi.org/10.1007/s10157-008-0114-x
Goncalves, I., Edsfeldt, A., Colhoun, H.M., Shore, A.C., Palombo, C., Natali, A., Fredrikson, G.N., Bjorkbacka, H., Wigren, M. and Bengtsson, E. (2016) Association between Renin and Atherosclerotic Burden in Subjects with and without Type 2 Diabetes. BMC Cardiovascular Disorders, 16, 171.
https://doi.org/10.1186/s12872-016-0346-8
Intantri, H.Y., Wijaya, A. and Patellongi, I. (2011) Association of Aldosterone, Plasma Renin Activity (PRA) and Superoxide Dismutase (SOD) with Inflammation and Insulin Resistance in Adult Men with Central Obesity. The Indonesian Biomedical Journal, 3, 116-121. https://doi.org/10.18585/inabj.v3i2.141
Umemura, S., Nyui, N., Tamura, K., Hibi, K., Yamaguchi, S., Nakamaru, M., Ishigami, T., Yabana, M., Kihara, M. and Inoue, S. (1997) Plasma Angiotensinogen Concentrations in Obese Patients. American Journal of Hypertension, 10, 629-633.
Hainault, I., Nebout, G., Turban, S., Ardouin, B., Ferré, P. and Quignard-Boulangé, A. (2002) Adipose Tissue-Specific Increase in Angiotensinogen Expression and Secretion in the Obese (fa/fa) Zucker Rat. American Journal of Physiology-Endocrinology and Metabolism, 282, E59-E66.
Engeli, S., Bohnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F.C. and Sharma, A.M. (2005) Weight Loss and the Renin-Angiotensin-Aldosterone System. Hypertension, 45, 356-362.
https://doi.org/10.1161/01.HYP.0000154361.47683.d3